Metastasis of Nasopharyngeal Carcinoma: What We Know and Do Not Know

Guo Ling-Ling,Wang Hai-Yun,Zheng Li-Sheng,Wang Ming-Dian,Cao Yun,Li Yang,Liu Zhi-Jie,Peng Li-Xia,Huang Bi-Jun,Shao Jian-Yong,Qian Chao-Nan
DOI: https://doi.org/10.1051/vcm/2021003
2021-01-01
Visualized Cancer Medicine
Abstract:Nasopharyngeal carcinoma (NPC) has the highest metastatic rate among head and neck cancers, with its underlying mechanism not yet fully unveiled. High- versus low-metastasis, NPC cell lines have been established. The footpad-popliteal lymph node metastasis model and other in vivo models have been stably used to study NPC metastasis. The histological appearance and the expression of epithelial-to-mesenchymal transition (EMT) markers might be helpful in selecting high-risk NPC patients for developing post-treatment metastasis. Tested EMT markers and their protein expression levels that correlate with patient disease-free survival in large patient cohorts include E-cadherin, N-cadherin, CD44, Twist, Snail, and Cyclin D1. Epstein-Barr virus (EBV) infection can trigger NPC metastasis from multiple angles via multiple signaling pathways. High endothelial venules are commonly seen in NPC tissues, with their role in NPC metastasis requiring clarification. The molecules that promote and inhibit NPC metastasis are introduced, with a focus on cytokines SPINK6, serglycin, interleukin 8 (IL8), Wnt family member 5A (WNT5A), and chemokine C-C motif ligand 2 (CCL2). Two videos showing NPC cells with and without SPINK6 knocked down are presented. Future directions for studying NPC metastasis are also discussed.
What problem does this paper attempt to address?